TITLE

An employer-based, pharmacist intervention model for patients with type 2 diabetes

AUTHOR(S)
IYER, RAVI; CODERRE, PAULINE; MCKELVEY, THERESA; COOPER, JASON; BERGER, JAN; MOORE, ELIZABETH; KUSHNER, MIKE
PUB. DATE
February 2010
SOURCE
American Journal of Health-System Pharmacy;2/15/2010, Vol. 67 Issue 4, p312
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Changes in glycosylated hemoglobin (HbA1c) levels, blood pressure measurements, and utilization metrics among diabetic patients managed by a clinical pharmacist were studied. Summary. This pharmacist intervention model was developed by Polk County, Florida, to engage patients with diabetes in managing their health based on the Asheville Project's framework. The diabetes program was implemented in February 2005, with an onsite clinical pharmacist to counsel participants with diabetes. The onsite pharmacist individualized each patient's care. After the initial assessment, educational deficiencies were noted and addressed as needed. Outcomes measured included changes in HbA1c, blood glucose, and blood pressure values and utilization metrics, such as hospitalization and emergency room visit rates, from baseline to one year after pharmacist intervention. Of the 564 participants who enrolled in the program, 477 were enrolled at the end of one year and were included in the analysis. Results showed that HbA1c values steadily decreased over the one-year study period. At baseline, there were 55% of participants with an average HbA1c value of ≤7%. After one year, 72% of participants had HbA1c values of ≤7%. Participants' mean systolic and diastolic blood pressure values were lower at the end of one year compared with the baseline. Participants also had a 30% reduction in hospital admissions, and the number of emergency room visits during the one-year period decreased by 24%. Conclusion. An employer-based pharmacist intervention model for patients with diabetes improved HbA1c levels, reduced systolic and diastolic blood pressure values, and decreased hospitalizations and emergency room visits after one year.
ACCESSION #
47924166

 

Related Articles

  • Advance Glycated End Products in Type 2 Diabetes Mellitus and Role of Dietary Supplement in their Management. Raina, Sindhwal; Ravi, Kant; Preeti, Kothiyal // International Journal of Pharmaceutical & Phytopharmacological R; 

    Advance glycated end products are a heterogeneous group of molecules formed from the non-enzymatic reaction of reducing sugars with free amino groups of proteins, lipids and nucleic acids. Advance glycation is an irreversible process, its physiological roles are to identify senescent proteins...

  • Safety and Efficacy of Modern Insulin Analogues. Hye Jin Yoo; Keun Yong Park; Kang Seo Park; Kyu Jeung Ahn; Kyung Wan Min; Jeong Hyun Park; Sang Ah Chang; Bong Soo Cha; Dong-Jun Kim; Yong Seong Kim; Tae Keun Oh; Suk Chon; Il Seong Nam-Goong; Mi Jin Kim; Hye-Soon Kim; Young Sik Choi; You Hem Ahn; Sora Leev; Sei Hyun Baik // Diabetes & Metabolism Journal;Jun2013, Vol. 37 Issue 3, p181 

    Background: Aichieve® was a noninterventional study evaluating the clinical safety and efficacy of biphasic insulin aspart 30, insulin detemir, and insulin aspart. Methods: Korean type 2 diabetes patients who have not been treated with the study insulin or have started it within 4 weeks...

  • Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials. Shanhu Qiu; Xue Cai; Xiang Chen; Bingquan Yang; Zilin Sun // BMC Medicine;2014, Vol. 12 Issue 1, p19 

    Background While step counter use has become popular among type 2 diabetes (T2D) patients, its effectiveness in increasing physical activity (PA) and improving glycemic control has been poorly defined. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the...

  • ROLE OF PERIODONTAL THERAPY IN TYPE II DIABETES MELLITUS. MAQSOOD, SHAHIDA; SOOMRO, MAQSOOD AHMED; BUTT, SAIMA AKRAM; AMIN, FAIZA; QADIR, FAUZIA; MAQSOOD, QURATULAIN // Pakistan Oral & Dental Journal;9/30/2014, Vol. 34 Issue 3, p486 

    The purpose of this study was to observe a gender based effect of periodontal therapy on glycaemic control of type II diabetes mellitus. This Interventional study was conducted on one hundred four patients suffering from type II diabetes mellitus, both gender were included from twenty five to...

  • Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial. Tang, An; Rabasa-Lhoret, Rémi; Castel, Hélène; Wartelle-Bladou, Claire; Gilbert, Guillaume; Massicotte-Tisluck, Karine; Chartrand, Gabriel; Olivié, Damien; Julien, Anne-Sophie; de Guise, Jacques; Soulez, Gilles; Chiasson, Jean-Louis // Diabetes Care;Jul2015  

    OBJECTIVE This study determined the effects of insulin versus liraglutide therapy on liver fat in patients with type 2 diabetes inadequately controlled with oral agents therapy, including metformin. RESEARCH DESIGN AND METHODS Thirty-five patients with type 2 diabetes inadequately controlled on...

  • The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes. Oyetayo, Ola O.; James, Clyde; Martinez, Anita; Roberson, Kim; Talbert, Robert L. // Journal of the American Pharmacists Association: JAPhA;Sep/Oct2011, Vol. 51 Issue 5, p623 

    Objective: To assess the impact of community pharmacists on clinical outcomes in Hispanic patients with type 2 diabetes. Methods: 126 patients were enrolled in this longitudinal pre/post cohort study that took place in nine community and four workplace pharmacies in San Antonio, TX. Pharmacists...

  • Hypertension management in diabetic patients. Anwer, Z.; Sharma, P.K.; Garg, V.K.; Kumar, N.; Kumari, A. // European Review for Medical & Pharmacological Sciences;2011, Vol. 15 Issue 11, p1258 

    Hypertension and diabetes are becoming increasingly common. Clinical trials have demonstrated the importance of tight blood pressure control among patients with diabetes. However, little is known regarding the management of hypertension in patients with coexisting diabetes. Most patients with...

  • Impact of Natriuretic Peptide Clearance Receptor (NPR3) Gene Variants on Blood Pressure in Type 2 Diabetes. SAULNIER, PIERRE-JEAN; ROUSSEL, RONAN; HALIMI, JEAN MICHEL; LEBREC, JEREMIE; DARDARI, DURED; MAIMAHIMING, SULYIA; GUILLOTEAU, GÉRARD; PRUGNARD, XAVIER; MARECHAUD, RICHARD; RAGOT, STEPHANIE; MARRE, MICHEL; HADJADJ, SAMY // Diabetes Care;May2011, Vol. 34 Issue 5, p1199 

    OBJECTIVE--Hypertension in diabetes is characterized by abnormal sodium homeostasis, suggesting a particular role of natriuretic peptide pathway. Natriuretic peptides can affect blood pressure (BP) through their plasma concentrations, which are dependent on their receptor activities. We thus...

  • Effect of Intensive Multifactorial Treatment Compared With Routine Care on Aortic Stiffness and Central Blood Pressure Among Individuals With Screen-Detected Type 2 Diabetes. JOHANSEN, NANNA B.; CHARLES, MORTEN; VISTISEN, DORTE; RASMUSSEN, SIGNE S.; WIINBERG, NIELS; BORCH.-JOHNSEN, KNUT; LAURITZEN, TORSTEN; SANDBÆK, ANNELLI; WITTE, DANIEL R. // Diabetes Care;Nov2012, Vol. 35 Issue 11, p2207 

    OBJECTIVE--Diabetes is associated with increased brachial and central blood pressure and aortic stiffness. We examined the effect of intensive multifactorial treatment in general practice on indices of peripheral and central hemodynamics among patients with screen-detected diabetes. RESEARCH...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics